Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

2 Biopharmaceutical Stocks Focused on Cancer That Wall Street Predicts Will More Than Double

Biopharmaceutical stocks are in focus on Monday after Bristol-Myers Squibb (BMY) announced an $11 billion partnership with BioNTech (BNTX) at the world’s largest cancer conference, the American Society for Clinical Oncology (ASCO), in Chicago. 

However, there are two other cancer-focused biopharma stocks, Actuate Therapeutics (ACTU) and PDS Biotechnology (PDSB), that analysts seem most bullish on for the next 12 months. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.